Kun Qian1,2, Shao Zhong2,3, Keming Xie2, Daozhan Yu2, Rongze Yang2, Da-Wei Gong2,4. 1. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 2. Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. 3. Department of Endocrinology and Metabolism Disease, Kunshan Hospital of Jiangsu University, Jiangsu, China. 4. VA Research Service, Geriatric Research, Education and Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, USA.
Abstract
BACKGROUND: Alanine transaminase (ALT) plays an important role in gluconeogenesis by converting alanine into pyruvate for glucose production. Early studies have shown that ALT activities are upregulated in gluconeogenic conditions and may be implicated in the development of diabetes. ALT consists of two isoforms, ALT1 and ALT2, with distinctive subcellular and tissue distributions. Whether and how they are regulated are largely unknown. METHODS: By using Western blotting analysis, we measured hepatic ALT isoforms at the protein level in obese and diabetic animals and in Fao hepatoma cells treated with dexamethasone and insulin. In addition, we measured glucose output in Fao cells over-expressing ALT1 and ALT2. RESULTS: Both ALT isoforms in the liver were increased in diabetic Goto-Kakizaki rats and during fasting. However, in ob/ob mice, only ALT2, but not ALT1, protein levels were elevated, and the increase of ALT2 was correlated with that of ALT activity. We further demonstrated that, in vitro, both ALT1 and ALT2 were induced by glucocorticoid dexamethasone, but suppressed by insulin in Fao cells. Finally, we showed that the over-expression of ALT1 and ALT2 in Fao cells directly increased glucose output. CONCLUSIONS: We have shown the similarity and difference in the regulation of ALT isoforms in gluconeogenic conditions at the protein level, supporting that ALT isoenzymes play an important role in glucose metabolism and may be implicated the development of insulin resistance and diabetes.
BACKGROUND:Alanine transaminase (ALT) plays an important role in gluconeogenesis by converting alanine into pyruvate for glucose production. Early studies have shown that ALT activities are upregulated in gluconeogenic conditions and may be implicated in the development of diabetes. ALT consists of two isoforms, ALT1 and ALT2, with distinctive subcellular and tissue distributions. Whether and how they are regulated are largely unknown. METHODS: By using Western blotting analysis, we measured hepatic ALT isoforms at the protein level in obese and diabetic animals and in Fao hepatoma cells treated with dexamethasone and insulin. In addition, we measured glucose output in Fao cells over-expressing ALT1 and ALT2. RESULTS: Both ALT isoforms in the liver were increased in diabetic Goto-Kakizaki rats and during fasting. However, in ob/ob mice, only ALT2, but not ALT1, protein levels were elevated, and the increase of ALT2 was correlated with that of ALT activity. We further demonstrated that, in vitro, both ALT1 and ALT2 were induced by glucocorticoid dexamethasone, but suppressed by insulin in Fao cells. Finally, we showed that the over-expression of ALT1 and ALT2 in Fao cells directly increased glucose output. CONCLUSIONS: We have shown the similarity and difference in the regulation of ALT isoforms in gluconeogenic conditions at the protein level, supporting that ALT isoenzymes play an important role in glucose metabolism and may be implicated the development of insulin resistance and diabetes.
Authors: Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant Journal: Atherosclerosis Date: 2006-05-08 Impact factor: 5.162
Authors: Jürgen G Okun; Patricia M Rusu; Andrea Y Chan; Yuqin Wu; Yann W Yap; Thomas Sharkie; Jonas Schumacher; Kathrin V Schmidt; Katherine M Roberts-Thomson; Ryan D Russell; Annika Zota; Susanne Hille; Andreas Jungmann; Ludovico Maggi; Young Lee; Matthias Blüher; Stephan Herzig; Michelle A Keske; Mathias Heikenwalder; Oliver J Müller; Adam J Rose Journal: Nat Metab Date: 2021-03-18
Authors: Yifei Lu; James R Pike; Elizabeth Selvin; Thomas Mosley; Priya Palta; A Richey Sharrett; Alvin Thomas; Laura Loehr; A Sidney Barritt; Ron C Hoogeveen; Gerardo Heiss Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160
Authors: Michael R Martino; Manuel Gutiérrez-Aguilar; Nicole K H Yiew; Andrew J Lutkewitte; Jason M Singer; Kyle S McCommis; Daniel Ferguson; Kim H H Liss; Jun Yoshino; M Katie Renkemeyer; Gordon I Smith; Kevin Cho; Justin A Fletcher; Samuel Klein; Gary J Patti; Shawn C Burgess; Brian N Finck Journal: Cell Rep Date: 2022-04-26 Impact factor: 9.995
Authors: Xiantong Zou; Prakash Ramachandran; Timothy J Kendall; Antonella Pellicoro; Elena Dora; Rebecca L Aucott; Kajal Manwani; Tak Yung Man; Karen E Chapman; Neil C Henderson; Stuart J Forbes; Scott P Webster; John P Iredale; Brian R Walker; Zoi Michailidou Journal: Hepatology Date: 2018-02-22 Impact factor: 17.425